Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension
- 31 October 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (10) , 1186-1203
- https://doi.org/10.1016/s0149-2918(00)83062-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Action of AT1 receptor antagonists on angiotensin II‐induced tone in human isolated subcutaneous resistance arteriesBritish Journal of Pharmacology, 1999
- Effects of candesartan cilexetil in patients with systemic hypertensionThe American Journal of Cardiology, 1998
- Candesartan vs losartanJournal of Human Hypertension, 1998
- Clinical Pharmacology of Multiple-Dose Losartan, an Angiotensin II Receptor Antagonist, in Patients with Essential HypertensionThe Journal of Clinical Pharmacology, 1996
- Controlled Trial of Losartan Given Concomitantly with Different Doses of Hydrochlorothiazide in Hypertensive PatientsBlood Pressure, 1996
- Studies of the renal effects of angiotensin II receptor blockade: The confounding factor of acute water loading on the action of vasoactive systemsAmerican Journal of Kidney Diseases, 1995
- Effects of Losartan on a Background of Hydrochlorothiazide in Patients With HypertensionHypertension, 1995
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertensionThe American Journal of Cardiology, 1995
- Blood pressure effects of the angiotensin II receptor blocker, losartanArchives of internal medicine (1960), 1995
- Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.Hypertension, 1991